Drug discovery for inflammatory diseases: 2-4 June 2003, Vienna, VA, USA

Expert Opinion on Biological Therapy

Volumn 3, Issue 6, 2003, Pages 1001-1004

  Rogatsky, Inez ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Cytokines and chemokines; Glucocorticoid receptor; Inflammation; Toll like receptors; Transcriptional activation and repression

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CANCER VACCINE; CHEMOKINE; CPG 7909; CYTOKINE; DEXAMETHASONE; DISSOCIATING AGONIST OF GLUCOCORTICOID RECEPTOR 1; DISSOCIATING AGONIST OF GLUCOCORTICOID RECEPTOR 2; FLUOROURACIL; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IMIQUIMOD; IMMUNE RESPONSE MODIFIER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; LEPTIN; LEPTIN RECEPTOR; MIFEPRISTONE; NUCLEAR RECEPTOR COACTIVATOR 2; OLIGODEOXYNUCLEOTIDE; PREDNISOLONE; PROTEIN KINASE; PROTEIN P160; RECOMBINANT LEPTIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ACADEMIC ACHIEVEMENT; ACTINIC KERATOSIS; ALLERGIC ENCEPHALITIS; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BASAL CELL CARCINOMA; BIOTECHNOLOGY; CANADA; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CONDYLOMA; CONFERENCE PAPER; CPG ISLAND; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG DESIGN; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; KIDNEY CARCINOMA; MEDICAL SOCIETY; MELANOMA; MULTIPLE SCLEROSIS; MUSCLE ATROPHY; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOPOROSIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; VACCINATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE THERAPY; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; TRANSCRIPTION FACTORS;

EID: 0041334128     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.3.6.1001     Document Type: Conference Paper

References (10)

1. MATARESE G, LA CAVA A, SANNA V et al: Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol. (2002) 23:182-187.
2. SANNA V, DI GIACOMO A, LA CAVA A et al.: Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. (2003) 111:241-250.
3. KRIEG AM: CpG motifs: the active ingredient in bacterial extracts? Nat. Med. (2003) 9:831-835.
4. BISHOP GA, HSING Y, HOSTAGER BS, JALUKAR SV, RAMIREZ LM, TOMAI MA: Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848. J. Immunol. (2000) 165:5552-5557.
5. GIBSON SJ, LINDH JM, RITER TR et al.: Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. (2002) 218:74-86.
6. LEFSTIN JA, YAMAMOTO KR: Allosteric effects of DNA on transcriptional regulators. Nature (1998) 392:885-888.
7. ROGATSKY I, ZAREMBER KA, YAMAMOTO KR: Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. (2001) 20:6071-6083.
8. ROGATSKY I, LUECKE HF, LEITMAN DC, YAMAMOTO KR: Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. USA (2002) 99:16701-16706.
9. BLACK P: Why is the prevalence of allergy and autoimmunity increasing? Trends Immunol. (2001) 22:354-355.
10. MATZINGER P: The danger model: a renewed sense of self. Science (2002) 296:301-305.